GPR37 is an Orphan-A GPCR with an unknown ligand. GPR37 was recently identified as the PAEL receptor, a Parkin substrate involved in autosomal recessive juvenile Parkinson's (PDJ) disease. The PAEL receptor becomes unfolded, insoluble, and ubiquitinated when overexpressed, leading to unfolded protein-induced cell death. When the PAEL receptor is ubiquitinated by Parkin, it gets degraded, resulting in the suppression of cell death. The insoluble form of the PAEL receptor accumulates in the brains of PDJ patients and may cause selective neuronal death. GPR37 expression has been reported in brain, liver, and placenta. ESTs have been isolated from brain, embryo, eye, fetal lung/testis/Bcell, gallbladder, heart, liver, liver/spleen, melanocyte/uterus/fetal heart, nerve, placenta, testis, tonsil, and vessel libraries.

Long Name

G Protein-coupled Receptor 37

Alternate Names

ETBR-LP-1, PAELR

Gene Symbol

GPR37

Additional GPR37 Products

Product Documents for GPR37 Antibody (436923) [Janelia Fluor® 549]

Product Datasheets

Download Product Datasheets

COA

SDS

Download SDS

Product Specific Notices for GPR37 Antibody (436923) [Janelia Fluor® 549]

Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Citations
Reviews

Spectra Viewer
Flow Cytometry

GPR37 Antibody (436923) [Janelia Fluor® 549]

Novus Biologicals, part of Bio-Techne | Catalog # FAB4450I

Key Product Details

Species Reactivity

Applications

Label

Antibody Source

Concentration

View all GPR37 Antibodies »

Product Specifications

Immunogen

Specificity

Clonality

Host

Isotype

Applications for GPR37 Antibody (436923) [Janelia Fluor® 549]

CyTOF-ready

Intracellular Staining by Flow Cytometry

Formulation, Preparation, and Storage

Purification

Formulation

Preservative

Concentration

Shipping

Stability & Storage

Background: GPR37